Loading clinical trials...
Loading clinical trials...
Randomized Phase II Study of Once Daily Accelerated Fractionation With Concomitant Boost to the Gross Tumor Volume Compared With Twice Daily Hyperfractionation in Concurrent Chemoradiation in Patients With Limited Disease Small Cell Lung Cancer
Conditions
Interventions
Arm 1: with twice-daily thoracic radiotherapy/ Arm 2: with once-daily thoracic radiotherapy
Locations
2
South Korea
National Cancer Canter, Korea
Ilsan-ro 323, Ilsandoung-gu, Goyang-si, Gyeonggi-do, South Korea
National Cancer Canter, Korea
Ilsan-ro 323, Ilsandoung-gu, Goyang-si, Gyeonggi-do, South Korea
Start Date
March 1, 2011
Primary Completion Date
December 1, 2014
Completion Date
December 1, 2014
Last Updated
October 19, 2012
Lead Sponsor
National Cancer Center, Korea
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions